Streamline Health Solns Q4 EPS $(0.02) Beats $(0.04) Estimate, Sales $5.36M Miss $5.49M Estimate
Portfolio Pulse from Benzinga Newsdesk
Streamline Health Solutions (STRM) reported Q4 earnings with losses of $(0.02) per share, beating estimates by 50%. However, their sales of $5.36M fell short of the $5.49M estimate, marking a 20.52% decrease from the previous year.
April 29, 2024 | 8:50 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Streamline Health Solutions reported better-than-expected Q4 EPS but missed sales estimates, with a significant year-over-year decrease.
The mixed results with an EPS beat but a miss on sales forecasts and a notable decrease in sales from the previous year could lead to neutral market sentiment. Investors might appreciate the cost management reflected in the reduced losses but be concerned about the declining sales.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100